Lu Zhang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI).

Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI).

Journal: Frontiers in pharmacology

Published: May 25, 2026

Deep Learning Enables Pixel-Level Nanoparticle Distribution Mapping in Routine Histological Sections by Integrating Cancer Associated Fibroblasts Features.

Deep Learning Enables Pixel-Level Nanoparticle Distribution Mapping in Routine Histological Sections by Integrating Cancer Associated Fibroblasts Features.

Journal: ACS nano

Published: March 27, 2026

A research protocol for a prospective, multicenter, cohort study on interferon therapy for chronic hepatitis B combined with metabolism-associated fatty liver disease to achieve clinical cure.

A research protocol for a prospective, multicenter, cohort study on interferon therapy for chronic hepatitis B combined with metabolism-associated fatty liver disease to achieve clinical cure.

Journal: Frontiers in public health

Published: December 16, 2024

18F-Labeled PET Tracers Specific for Adenosine A2A Receptor: Design, Synthesis, and Biological Evaluation.

18F-Labeled PET Tracers Specific for Adenosine A2A Receptor: Design, Synthesis, and Biological Evaluation.

Journal: ACS chemical neuroscience

Published: March 08, 2024

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment.

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment.

Journal: Frontiers in immunology

Published: December 05, 2022

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection.

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection.

Journal: Frontiers in immunology

Published: November 30, 2022

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection.

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection.

Journal: Frontiers in immunology

Published: October 05, 2022

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug-induced liver injury.

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug-induced liver injury.

Journal: Frontiers in pharmacology

Published: June 09, 2022

Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection.

Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection.

Journal: Hepatology international

Published: June 03, 2022

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients.

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients.

Journal: Frontiers in microbiology

Published: June 03, 2022

Novel 18F-Labeled PET Tracers Specific to Aromatase: Design, Synthesis, and Biological Evaluation.

Novel 18F-Labeled PET Tracers Specific to Aromatase: Design, Synthesis, and Biological Evaluation.

Journal: Molecular pharmaceutics

Published: May 27, 2022

[18F]BIBD-181: A Novel Positron Emission Tomography Tracer Specific for Synaptic Vesicle Glycoprotein 2A.

[18F]BIBD-181: A Novel Positron Emission Tomography Tracer Specific for Synaptic Vesicle Glycoprotein 2A.

Journal: ACS medicinal chemistry letters

Published: February 14, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026